Literature DB >> 10859512

Stevens-Johnson syndrome in India - risk factors, ocular manifestations and management.

N Pushker1, R Tandon, R B Vajpayee.   

Abstract

We conducted a study to analyse the presentation, risk factors, ocular manifestations and ophthalmic management results of Stevens-Johnson syndrome (SJS) in Indian patients. A total of 20 patients with SJS with ocular involvement were studied. Female predominance (70%) was observed. The age ranged from 10 to 30 years (mean +/- SD: 16.85 +/- 5.96). The commonest precipitating risk factor was oral drug intake (80%), sulphonamide (30%; sulphamethoxazole-trimethoprim) being the commonest. One patient had reaction to ciprofloxacin which has not been reported previously. Four patients (20%) had spontaneous onset with no identifiable risk factor. None of the patients had specific infection per se as a risk factor. Conjunctival involvement and its sequelae were the major ocular manifestations. At presentation, the majority of the eyes (68%) had visual acuity less than 3/60. Despite appropriate medical treatment and surgical interventions (11 eyes; 28%) vision continued to deteriorate. In 1 eye, the vision improved after stem cell transplantation. Therapeutic penetrating keratoplasty could preserve ocular integrity in 1 patient. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859512     DOI: 10.1159/000027505

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

1.  Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.

Authors:  Hye-In Kim; Shin-Woo Kim; Ga-Young Park; Eu-Gene Kwon; Hyo-Hoon Kim; Ju-Young Jeong; Hyun-Ha Chang; Jong-Myung Lee; Neung-Su Kim
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

2.  Stevens Johnson syndrome and neurotoxic effects of metronidazole.

Authors:  Rahul Magazine; Bharti Chogtu
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

3.  An analysis of drug induced Stevens-Johnson syndrome.

Authors:  P P Patel; A M Gandhi; C K Desai; M K Desai; R K Dikshit
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.